Medline revenue and financials

MDLN · NASDAQ · USD

Compare Medline
$37.04Change from previous close: −2.11%Absolute change: −$0.80

Close · November 20, 2026

In the fiscal year ended December 2025, Medline reported revenue of $28.43B (+11.47% year over year). Net income was $1.16B, a net margin of 4.1%.

Annual revenue · 2025: $28.43B
  1. $21.45B2022
  2. $23.23B2023
  3. $25.51B2024
  4. $28.43B2025

Fiscal year ending in December. Sources and method on the page How we analyse stocks.

At a glance

Revenue growth
+11.47%
2025 vs 2024
Net income growth
−3.42%
2025 vs 2024
Net margin
4.1%
2024: 4.7%

How Medline is changing

Calculated from the annual statements; each fiscal year is labelled with the year it ends.

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Annual
Item2025202420232022
Total revenue28,43225,50723,23121,448
Cost of revenue20,91418,53117,34616,231
Gross profit7,5186,9765,8855,217
Selling, general and administrative4,5674,1083,8673,676
Research and development80.067.060.0—
Operating income2,1792,1481,411861
EBIT2,1792,1481,411861
EBITDA3,1903,1252,3621,794
Interest expense9451,1441,213899
Pre-tax income1,2481,24626410.0
Income tax91.046.030.035.0
Net income1,1591,200234-25.0
Net income to common shareholders1,1591,200234-25.0
Basic EPS1.430.070.01-0.01
Diluted EPS1.430.070.01-0.01
Average shares (basic)81017,46717,5001,828
Average shares (diluted)81017,46717,5001,828

Companies in the group: same industry, similar size